|
11 |
Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling
Sachen, Kacey L.. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2025
|
|
|
|
12 |
IL‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: a prospective cohort study
Reimer-Taschenbrecker, Antonia. - Freiburg : Universität, 2024
|
|
|
|
13 |
Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasis
Jargosch, Manja. - Freiburg : Universität, 2025
|
|
|
|
14 |
Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis
Murase, Jenny E.. - Freiburg : Universität, 2025
|
|
|
|
15 |
Lebrikizumab rapidly lowers inflammatory biomarkers with clinical correlations in moderate-to-severe atopic dermatitis
Guttman‐Yassky, Emma. - Freiburg : Universität, 2025
|
|
|
|
16 |
Oral peptide therapeutics as an emerging treatment modality in immune-mediated inflammatory diseases: a narrative review
Stein Gold, Linda F.. - Freiburg : Universität, 2025
|
|
|
|
17 |
Rapid itch improvement and skin clearance with upadacitinib versus placebo (measure up 1 and measure up 2) and versus dupilumab (heads up): results from three phase 3 clinical trials in patients with moderate-to-severe atopic dermatitis
Simpson, Eric L.. - Freiburg : Universität, 2025
|
|
|
|
18 |
Scabies management outcomes: identification of risk factors for treatment success or failure
Azzolina, Vanessa. - Freiburg : Universität, 2025
|
|
|
|
19 |
Skin deep and beyond: unravelling B cell extracellular matrix interactions in cutaneous immunity and disease
Diehl, Rebecca. - Freiburg : Universität, 2025
|
|
|
|
20 |
The Translational Dermatology Initiative: Aiming at a New Disease Classification of Inflammatory Skin Diseases
Jonsson, Pontus. - Freiburg : Universität, 2025
|
|
Administration
